135 related articles for article (PubMed ID: 16409972)
21. Impaired human gallbladder lipid absorption in cholesterol gallstone disease and its effect on cholesterol solubility in bile.
Corradini SG; Elisei W; Giovannelli L; Ripani C; Della Guardia P; Corsi A; Cantafora A; Capocaccia L; Ziparo V; Stipa V; Chirletti P; Caronna R; Lomanto D; Attili AF
Gastroenterology; 2000 May; 118(5):912-20. PubMed ID: 10784590
[TBL] [Abstract][Full Text] [Related]
22. Distribution changes of interstitial cells of Cajal during cholesterol gallstone formation in guinea pigs fed a high cholesterol diet.
Huang ZP; Qiu H; Yu BP
Int J Clin Exp Pathol; 2018; 11(3):1653-1659. PubMed ID: 31938265
[TBL] [Abstract][Full Text] [Related]
23. Role of ROCK expression in gallbladder smooth muscle contraction.
Wang B; Ding YM; Wang CT; Wang WX
Mol Med Rep; 2015 Aug; 12(2):2907-11. PubMed ID: 25955570
[TBL] [Abstract][Full Text] [Related]
24. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
Wang HH; Portincasa P; Wang DQ
Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129
[TBL] [Abstract][Full Text] [Related]
25. The role of interstitial Cajal-like cells in the formation of cholesterol stones in guinea pig gallbladder.
Fan Y; Wu S; Fu B; Weng C; Wang X
Hepatol Int; 2015 Oct; 9(4):612-20. PubMed ID: 25788205
[TBL] [Abstract][Full Text] [Related]
26. Drugs affecting biliary lipid secretion and gallbladder motility: their potential role in gallstone treatment and prevention.
vanBerge-Henegouwen GP; Venneman NG; van Erpecum KJ; Portincasa P
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Jun; 5(2):185-91. PubMed ID: 16089351
[TBL] [Abstract][Full Text] [Related]
27. Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution.
Festi D; Frabboni R; Bazzoli F; Sangermano A; Ronchi M; Rossi L; Parini P; Orsini M; Primerano AM; Mazzella G
Gastroenterology; 1990 Dec; 99(6):1779-85. PubMed ID: 2227291
[TBL] [Abstract][Full Text] [Related]
28. Effects of sphincter of Oddi motility on the formation of cholesterol gallstones.
Rong ZH; Chen HY; Wang XX; Wang ZY; Xian GZ; Ma BZ; Qin CK; Zhang ZH
World J Gastroenterol; 2016 Jun; 22(24):5540-7. PubMed ID: 27350732
[TBL] [Abstract][Full Text] [Related]
29. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
Sahlin S
Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
[TBL] [Abstract][Full Text] [Related]
30. The potential site of disordered gallbladder contractility during the early stage of cholesterol gallstone formation.
Mansour A; Dawoud I; Gad-El-Hak N
Hepatogastroenterology; 1998; 45(23):1404-9. PubMed ID: 9840074
[TBL] [Abstract][Full Text] [Related]
31. Castanea sativa Mill. extract contracts gallbladder and relaxes sphincter of Oddi in guinea pig: a natural approach to biliary tract motility disorders.
Micucci M; Ioan P; Aldini R; Cevenini M; Alvisi V; Ruffilli C; Chiarini A; Budriesi R
J Med Food; 2014 Jul; 17(7):795-803. PubMed ID: 24654975
[TBL] [Abstract][Full Text] [Related]
32. [Regulatory effect of clearing-heat secreting-bile regulating-qi flow and activating blood circulation principle on cholecystokinin receptor].
Fu HQ; Wu WD; Zou SB
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 May; 23(5):367-9. PubMed ID: 12800421
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of gallstone formation by sphincterotomy in the prairie dog: reversal by atropine.
Hutton SW; Sievert CE; Vennes JA; Duane WC
Gastroenterology; 1982 Jun; 82(6):1308-13. PubMed ID: 7067954
[TBL] [Abstract][Full Text] [Related]
34. Effects of combined treatment with pravastatin and ursodeoxycholic acid on hepatic cholesterol metabolism.
Hillebrant CG; Nyberg B; Gustafsson U; Sahlin S; Björkhem I; Rudling M; Einarsson C
Eur J Clin Invest; 2002 Jul; 32(7):528-34. PubMed ID: 12153554
[TBL] [Abstract][Full Text] [Related]
35. Gallstone recurrence after successful dissolution therapy.
Tudyka J; Wechsler JG; Kratzer W; Maier C; Mason R; Kuhn K; Adler G
Dig Dis Sci; 1996 Feb; 41(2):235-41. PubMed ID: 8601364
[TBL] [Abstract][Full Text] [Related]
36. Ursodeoxycholic acid reduces protein levels and nucleation-promoting activity in human gallbladder bile.
Van Erpecum KJ; Portincasa P; Eckhardt E; Go PM; VanBerge-Henegouwen GP; Groen AK
Gastroenterology; 1996 Apr; 110(4):1225-37. PubMed ID: 8613013
[TBL] [Abstract][Full Text] [Related]
37. Occurrence of cholesterol monohydrate crystals in gallbladder and hepatic bile in man: influence of bile acid treatment.
Sahlin S; Ahlberg J; Angelin B; Ewerth S; Nilsell K; Reihnér E; Einarsson K
Eur J Clin Invest; 1988 Aug; 18(4):386-90. PubMed ID: 3139424
[TBL] [Abstract][Full Text] [Related]
38. [Oil of Piper longum unsaponifiable matter prevents cholesterol gallstone formation].
Xu S; Hu JF; Chu SF; Han N; Li JW; Li YT; Chen NH
Yao Xue Xue Bao; 2013 Jul; 48(7):1178-82. PubMed ID: 24133988
[TBL] [Abstract][Full Text] [Related]
39. The effects of prosthetic gallstones on gallbladder function and bile composition.
Pomeranz IS; Davison JS; Shaffer EA
J Surg Res; 1986 Jul; 41(1):47-52. PubMed ID: 3747496
[TBL] [Abstract][Full Text] [Related]
40. Bile lithogenicity and gallbladder emptying in patients with microlithiasis: effect of bile acid therapy.
Sharma BC; Agarwal DK; Dhiman RK; Baijal SS; Choudhuri G; Saraswat VA
Gastroenterology; 1998 Jul; 115(1):124-8. PubMed ID: 9649467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
